2. Signaling Pathways
  3. Others
  4. Others

Others

 
Cat. No. Product Name Effect Purity Chemical Structure
  • HY-P10629
    PSMα2
    		98.81%
    PSMα2 is a potent PSM (phenol-soluble modulin) peptide toward mouse neutrophils, led to strong influx of leukocytes.
    PSMα2
  • HY-116442
    Azapropazone
    		99.67%
    Azapropazone is a nonsteroidal anti-inflammatory agent (NSAID). Azapropazone can be used for the research of rheumatoid arthritis and other rheumatoid conditions.
    Azapropazone
  • HY-103317
    NAADP
    NAADP, a nucleotide, is a Ca2+-mobilizing second messenger. NAADP is essential for initiation of Ca2+ signaling.
    NAADP
  • HY-P991207
    Human IgG1 (L234A/L235A) kappa, Isotype Control
    Human IgG1 (L234AL235A) kappa, Isotype Control, a human monoclonal antibody, is an isotype control for human IgG1κantibody.
    Human IgG1 (L234A/L235A) kappa, Isotype Control
  • HY-164710
    Biotinylated leptomycin B
    		99.32%
    Biotinylated leptomycin B is a compound used to quantify nuclear export protein 1 (XPO1) occupancy and is used to study the interaction of SINE compounds with XPO1 and the response of cancer cells to related compounds.
    Biotinylated leptomycin B
  • HY-159681
    AASS-IN-1
    		98.40%
    AASS-IN-1 (Compound S-105) is an AASS (2-aminoadipic semialdehyde synthase) inhibitor with an IC50 value of 142 μM. AASS-IN-1 inhibits AASS activity by binding to the LOR domain of AASS. AASS-IN-1 holds potential for research in the field of hyperlysinemia.
    AASS-IN-1
  • HY-112722
    Neurotoxin Inhibitor
    		99.02%
    Neurotoxin Inhibitor is a neurotoxin inhibitor.
    Neurotoxin Inhibitor
  • HY-119694
    Rotenolone
    Rotenolone is an antiproliferative agent. Rotenolone shows antiproliferative activity against the ovarian cancer A2780, breast cancer BT-549, prostate cancer DU 145, NSCLC NCI-H460, and colon cancer HCC-2998 cell lines, with IC50s of 0.95, 1.6, 2.7, 2.0, and 2.9 μM, respectively.
    Rotenolone
  • HY-139059
    ERD03
    		Inhibitor 99.39%
    ERD03 is a potent disruptor of the EXOSC3-RNA interaction, with a Kd of 17±7 μM . ERD03 induces PCH1B-like phenotype in zebrafish embryo and can be used for neurological disorder disease research.
    ERD03
  • HY-B0950A
    Mefexamide hydrochloride
    		99.45%
    Mefexamide hydrochloride is a particular psychostimulant that is capable of reversing the psychodepressant effects induced by diazepam and benzodiazepine sedatives.
    Mefexamide hydrochloride
  • HY-135818
    XM462
    		99.80%
    XM462 is a dihydroceramide desaturase inhibitor. XM462 produced a mixed-type inhibition (Ki=2 μM) in vitro. XM462 has dihydroceramide desaturase inhibition both in vitro and in cultured cells with IC50 values of 8.2 and 0.78 μM, respectively. XM462 can be used for the research of tumor.
    XM462
  • HY-149325
    RPE65-IN-1
    		≥98.0%
    RPE65-IN-1(Compound 16e) is a potent RPE65 inhibitor, with an IC50 value of 0.29 μM. which can be used in retinopathy-related research.
    RPE65-IN-1
  • HY-121890
    Etoxybamide
    Etoxybamide is a sedative. Etoxybamide has sedative and hypnotic effects.
    Etoxybamide
  • HY-156775
    Antitumor agent-119
    		98.03%
    Antitumor agent-119 (compound 13K) is a 2-benzoxazolyl hydrazone derivative with anticancer activities. Antitumor agent-119 inhibits the cell growth of Butkitt, CCRF-CEM, HeLa, and HT-29 with IC50 values of 30 nM, 140 nM, 100 nM, and 40 nM, respectively.
    Antitumor agent-119
  • HY-143539
    YQ456
    		99.84%
    YQ456 is a novel small molecule inhibitor of myoferlin that showed high binding affinity to myoferlin with a KD of 37 nM and excellent anti-invasion capability with an IC50 of 110 nM.
    YQ456
  • HY-161904
    CDYL-IN-1
    		Inhibitor 99.80%
    CDYL-IN-1 (compound D03) is a CDYL inhibitor, with a KD of 0.5 μM. CDYL-IN-1 can be used in the research of acute kidney injury.
    CDYL-IN-1
  • HY-16395
    PG-11047
    		98.0%
    PG-11047 (CGC-11047) is a polyamine analogue. PG-11047 can be used for the research of breast cancer.
    PG-11047
  • HY-122610
    VUT-MK142
    		99.57%
    VUT-MK142 is a potent new cardiomyogenic synthetic agent promoting the differentiation of pre-cardiac mesoderm into cardiomyocytes, which may be useful to differentiate stem cells into cardiomyocytes for cardiac repair.
    VUT-MK142
  • HY-153419
    BTTES
    		98.40%
    BTTES is a tris(triazolylmethyl)amine-based ligand for Cu(I) without apparent toxicity. BTTES IMPROVES the cycloaddition reaction rapidly in living systems.
    BTTES
  • HY-W016366
    2-Chlorocinnamic acid
    		99.87%
    2-Chlorocinnamic acid is a kind of trans-cinnamate.
    2-Chlorocinnamic acid
Cat. No. Product Name / Synonyms Application Reactivity